A perspective on the current role of teprotumumab in treatment of thyroid eye disease
RC Allen, EA Bradley, RG Fante, MJ Lucarelli - Ophthalmology, 2021 - aaojournal.org
The arrival of teprotumumab has been hailed as a gamechanger in the treatment of thyroid
eye disease (TED). 1 This monoclonal antibody to the insulin-like growth factor-1 receptor is …
eye disease (TED). 1 This monoclonal antibody to the insulin-like growth factor-1 receptor is …
[引用][C] A Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease.
RC Allen, EA Bradley, RG Fante, MJ Lucarelli - Ophthalmology, 2021 - europepmc.org
[引用][C] A Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease
RC Allen, EA Bradley, RG Fante… - …, 2021 - pubmed.ncbi.nlm.nih.gov
A Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease A
Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease …
Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease …